Sandra Barth

Sandra Barth has a diverse work experience spanning various roles and industries. Sandra started their career as a Post-Doc at the University of Stuttgart - Institute of Technical Biochemistry in January 2004. After a year, they transitioned to Philips Medizinsysteme Böblingen as an R&D Engineer, where they worked from February 2005 to August 2007. Sandra then joined Curetis Group, initially as a Scientist from September 2007 to October 2008, and then as a Senior Scientist from November 2008 to May 2019. Their responsibilities expanded further when they became a Senior Project Manager at Curetis Group from June 2019 to December 2022. Currently, Sandra Barth holds the position of Head of Clinical Trial Operations at Curetis Group, starting in January 2023.

Sandra Barth pursued their education at the University of Stuttgart from 1997 to 2003, where they obtained a Ph.D. in Technische Biologie. Prior to that, they attended the Universität Karlsruhe from 1994 to 1997, earning a Vordiplom in Chemieingenieurwesen.